Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Moving to better COPD care-changes to and challenges for GOLD.
American journal of respiratory and critical care medicine·2026
Same author
Does Inhaled Marijuana Use Have an Adverse Effect On Asthma?: An Incomplete Answer.
Chest·2026
Same author
Diagnostic criteria for invasive pulmonary aspergillosis in COPD patients.
American journal of respiratory and critical care medicine·2026
Related Experiment Video
Updated: Jun 19, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Defining disease modification in chronic obstructive pulmonary disease.
David M G Halpin1, Donald P Tashkin
1Royal Devon and Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK. david.halpin@rdeft.nhs.uk
COPD
|October 9, 2009
Summary
Defining disease modification in chronic obstructive pulmonary disease (COPD) is crucial. A new definition clarifies that interventions must improve or stabilize structural/functional parameters to be considered disease-modifying for COPD.
More Related Videos
Area of Science:
- Pulmonary Medicine
- Respiratory Research
- Clinical Therapeutics
Background:
- Chronic obstructive pulmonary disease (COPD) presents a significant global health burden.
- Current interventions for COPD primarily manage symptoms and complications.
- Few interventions have definitively shown the ability to modify COPD disease progression.
Purpose of the Study:
- To establish a clear, working definition for disease modification in COPD.
- To identify appropriate markers for evaluating disease modification in COPD interventions.
- To address the complexities in assessing interventions that may alter COPD progression.
Main Methods:
- Convening a multidisciplinary working group of international physicians and scientists.
- Facilitating discussions to reach a consensus on disease modification.
- Developing a formal definition for disease modification based on structural and functional parameters.
Main Results:
- A proposed working definition for disease modification was established.
- Disease modification is defined as improving or stabilizing structural/functional parameters by reducing their progression rate during intervention.
- This modification may persist even after intervention withdrawal.
Conclusions:
- Pharmacologic interventions can be disease-modifying if they yield sustained improvements in structural and functional parameters.
- Smoking cessation and lung volume reduction surgery are identified as disease-modifying interventions for COPD.
- A standardized definition is essential for accurately evaluating COPD progression and treatment efficacy.